NCT05560100View on ClinicalTrials.gov

Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Dry Needling
Interventions
OTHER

Nominal Group Technique - 2 to 3 hour virtual meeting

Participants will be invited to a 2-3 online virtual online meeting with the goal of constructing and defining elements for producing a risk statement for dry needling that can be used for informed consent.

Trial Locations (1)

44555

Youngstown State University, Youngstown

All Listed Sponsors
lead

Youngstown State University

OTHER